🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Defocus-Enhanced vs. Single Vision Spectacles in Myopia Control Visual Function Training

RecruitingNAAges 6 Years - 18 YearsAllBeijing Visionly Plus Eye Hospital
NCT06821074 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to compare the effectiveness of vision function training using defocus-enhanced spectacles (DIMS) versus single vision spectacles combined with vision function training in controlling myopia progression in children aged 6-18 years.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Aged 6-18 years. * Diagnosed myopia with SER between -0.50D and -4.00D. * Astigmatism ≤ 2.50DC. * Anisometropia \< 1.25D. Exclusion Criteria: * Suspected genetic syndromes (e.g., Stickler, Marfan). * Other eye diseases (e.g., glaucoma, cataracts, retinal abnormalities, strabismus). * Myopia progression \<0.50D SER in the last year.
💊

What it tests

  • Defocus-enhanced spectacles
  • Single vision spectacles
📍

Where

2 sites
Beijing New Vision Eye Hospital
Beijing, China
Beijing Visionly Plus Eye Hospital
Beijing, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy